User:Mr. Ibrahem/Bictegravir/emtricitabine/tenofovir alafenamide

Bictegravir/emtricitabine/tenofovir alafenamide, sold under the brand name Biktarvy, is a combination medication used to treat HIV/AIDS. It is taken by mouth as one tablet a day. It is used in people who weight more than 14 kg.

Common side effects include diarrhea, nausea, and headache. Other side effects may include immune reconstitution syndrome, kidney problems, liver problems, and lactic acidosis. Safety in pregnancy is unclear. It is a combination of bictegravir, an integrase inhibitor; and emtricitabine and tenofovir alafenamide, both nucleoside reverse transcriptase inhibitor (NRTIs).

The combination was approved for medical use in the United States and Europe in 2018. In the United Kingdom a month of medication costs the NHS about £880 as of 2021. This amount in the United States costs about 3,500 USD.